WallStSmart
SSKN

STRATA Skin Sciences Inc

NASDAQ: SSKN · HEALTHCARE · MEDICAL DEVICES

$0.14
+3.92% today

Updated 2026-04-29

Market cap
$824350.00
P/E ratio
P/S ratio
0.03x
EPS (TTM)
$-1.35
Dividend yield
52W range
$0 – $4
Volume
0.1M

STRATA Skin Sciences Inc (SSKN) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
2 of 8
Last 8 quarters
Avg EPS surprise
+84.1%
Last 4 quarters
Revenue YoY growth
-21.2%
Most recent quarter
EPS YoY growth
+30.9%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
-19.0%
Last 1 reports
Positive reaction rate
0%
0 of 1 quarters
Largest single-day move
-19.0%
2025-11-13
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2025-11-13$-0.36-1300.0%$1.68$1.36-19.0%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2025-09-30$0.03$-0.36-1300.0%$6.93M-21.2%
2025-06-30$0.01$-0.60-6100.0%$7.66M-9.2%
2025-03-31$-0.56$-0.58-3.6%$6.81M+0.9%
2024-12-31$-0.40$0.29+171.8%$9.58M+10.2%
2024-09-30$-0.44$-0.52-18.3%$8.80M-0.6%
2024-06-30$-0.70$-0.03+95.7%$8.44M+2.2%
2024-03-31$-0.07$-0.10-42.9%$6.75M-10.7%
2023-12-31$-0.02$-0.11-450.0%$8.69M
2023-09-30$-0.04$-0.03+25.0%$8.85M
2023-06-30$-0.05$-0.06-20.0%$8.25M
2023-03-31$-0.07$-0.08-14.3%$7.57M
2022-12-31$-0.05$0.05+190.0%

Frequently asked questions

Has STRATA Skin Sciences Inc beaten earnings estimates?
STRATA Skin Sciences Inc has beaten Wall Street EPS estimates in 2 of its last 8 quarterly reports, with an average EPS surprise of +84.1% over the last 2 quarters.
How does SSKN stock react to earnings?
SSKN stock has moved an average of -19.0% in the trading day following earnings over its last 1 reports, with positive reactions in 0% of those quarters.
What is STRATA Skin Sciences Inc's revenue growth rate?
STRATA Skin Sciences Inc reported year-over-year revenue growth of -21.2% in its most recent quarter, with EPS growing +30.9% year-over-year.